VIXBRU

Serial Number 98859212
688

Registration Progress

Application Filed
Nov 18, 2024
Under Examination
Jun 24, 2025
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered

Basic Information

Serial Number
98859212
Deadline
December 24, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
November 18, 2024
Published for Opposition
April 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 24, 2025
Application
Pending
Classes
005

Rights Holder

ONO PHARMACEUTICAL CO., LTD.

03
Address
1-5, Doshomachi 2-chome, Chuo-ku,
Osaka-shi, Osaka 541-8526
JP

Ownership History

ONO PHARMACEUTICAL CO., LTD.

Original Applicant
03
Osaka-shi, Osaka JP

ONO PHARMACEUTICAL CO., LTD.

Owner at Publication
03
Osaka-shi, Osaka JP

Legal Representation

Attorney
Perla M. Kuhn
USPTO Deadlines 2 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUBE May 29, 2025 39 days overdue Medium Until Jun 29, 2025
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAME Dec 24, 2025 170 days High Until Jun 24, 2026
Next deadline: Notice of Allowance Mailed - SOU Required on December 24, 2025 (170 days)

Application History

8 events
Date Code Type Description
Jun 24, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2025 DOCK D ASSIGNED TO EXAMINER
Nov 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Active Deadlines

Notice of Publication
Due: May 29, 2025 Overdue
Notice of Allowance Mailed - SOU Required
Due: Dec 24, 2025

Classification

International Classes
005